A Hidden Opportunity - Medicaid's Role in Supporting Equitable Access to Clinical Trials

Overview

Journal N Engl J Med

Specialty General Medicine

Date 2021 May 27

PMID 34043298

Citations 10

Authors

Samuel U Takvorian

Carmen E Guerra

William L Schpero

Affiliations

Soon will be listed here.

Citing Articles

Association Between State Medicaid Policies and Accrual of Black or Hispanic Patients to Cancer Clinical Trials.

Schpero W, Takvorian S, Blickstein D, Shafquat A, Liu J, Chatterjee A J Clin Oncol. 2024; 42(27):3238-3246.

PMID: 39052944 PMC: 11408099. DOI: 10.1200/JCO.23.01149.

Impact of the Affordable Care Act on access to accredited facilities for cancer treatment.

Sabik L, Kwon Y, Drake C, Yabes J, Bhattacharya M, Sun Z Health Serv Res. 2024; 59(6):e14315.

PMID: 38698670 PMC: 11622264. DOI: 10.1111/1475-6773.14315.

Greater Investments in Safety Net Health Systems Can Help Diversify Participation in Clinical Trials and Research.

Coronado G, Anyane-Yeboa A, Byhoff E, Escaron A, Sonik R, Talamantes E J Gen Intern Med. 2023; 39(2):312-315.

PMID: 37884838 PMC: 10853098. DOI: 10.1007/s11606-023-08489-6.

"There's not enough studies": Views of black breast and ovarian cancer patients on research participation.

Riggan K, Rousseau A, Halyard M, James S, Kelly M, Phillips D Cancer Med. 2023; 12(7):8767-8776.

PMID: 36647342 PMC: 10134334. DOI: 10.1002/cam4.5622.

Enrollment Lessons from a Biological Assignment Study of Marrow Transplantation versus Standard Care for Adolescents and Young Adults with Sickle Cell Disease: Considerations for Future Gene and Cellular Therapy Trials.

Krishnamurti L, Neuberg D, Sullivan K, Smith S, Eapen M, Walters M Transplant Cell Ther. 2022; 29(4):217-221.

PMID: 36270432 PMC: 10539686. DOI: 10.1016/j.jtct.2022.10.008.

References

Yancey A, Ortega A, Kumanyika S . Effective recruitment and retention of minority research participants. Annu Rev Public Health. 2006; 27:1-28. DOI: 10.1146/annurev.publhealth.27.021405.102113. View

Ghebre R, Jones L, Wenzel J, Martin M, Durant R, Ford J . State-of-the-science of patient navigation as a strategy for enhancing minority clinical trial accrual. Cancer. 2014; 120 Suppl 7:1122-30. PMC: 4039342. DOI: 10.1002/cncr.28570. View

Duma N, Vera Aguilera J, Paludo J, Haddox C, Gonzalez Velez M, Wang Y . Representation of Minorities and Women in Oncology Clinical Trials: Review of the Past 14 Years. J Oncol Pract. 2017; 14(1):e1-e10. DOI: 10.1200/JOP.2017.025288. View

Chastain D, Osae S, Henao-Martinez A, Franco-Paredes C, Chastain J, Young H . Racial Disproportionality in Covid Clinical Trials. N Engl J Med. 2020; 383(9):e59. DOI: 10.1056/NEJMp2021971. View

Loree J, Anand S, Dasari A, Unger J, Gothwal A, Ellis L . Disparity of Race Reporting and Representation in Clinical Trials Leading to Cancer Drug Approvals From 2008 to 2018. JAMA Oncol. 2019; 5(10):e191870. PMC: 6696743. DOI: 10.1001/jamaoncol.2019.1870. View